GWSG
HRMY icon

GPS Wealth Strategies Group’s Harmony Biosciences HRMY Stock Holding History

GPS Wealth Strategies Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$8.27K – 998
2025
Q3 		$8.27K Sell
300
-250
-45% -$8.61K ﹤0.01% 1137
2025
Q2 		$17.4K Buy
+550
New +$17.7K ﹤0.01% 889

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GPS Wealth Strategies Group's HRMY Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 300 shares — an estimated $8.27K sold.

GPS Wealth Strategies Group first reported a position in HRMY in Q2 2025 and held it in 2 quarters. The position peaked at $17.4K in Q2 2025. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 300 Harmony Biosciences shares in Q4 2025, an estimated $8.27K.
  • GPS Wealth Strategies Group first reported a position in Harmony Biosciences in Q2 2025 and held it in 2 quarters.
  • GPS Wealth Strategies Group's Harmony Biosciences position peaked at $17.4K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.